Author | David J. Straus, MD | OncLive

Author | David J. Straus, MD

Articles

Dr. Straus on the 3-Year Results of the ECHELON-1 Study in Hodgkin Lymphoma

July 31, 2019

Video

David J. Straus, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the 3-year follow-up results of the ECHELON-1 study, which examines brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma.

Dr. Straus on FDA Approval of Pembrolizumab in Hodgkin Lymphoma

March 15, 2017

Video

David J. Straus, MD, internist and hematologic oncologist, Memorial Sloan Kettering Cancer Center, discusses the FDA approval of pembrolizumab (Keytruda) as a treatment for patients with Hodgkin lymphoma.

Dr. Straus on Ongoing Clinical Trials in Hodgkin Lymphoma

February 15, 2017

Video

David J. Straus, MD, an internist and hematologic oncologist at Memorial Sloan Kettering Cancer Center, discusses ongoing clinical trials in the field of Hodgkin lymphoma.

x